World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

World Top Biopharmaceutical Companies 2024
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.

  1. Opthea Limited

    World Rank (Jan-05-2024)
    16,232
    Market Cap (Jan-05-2024)
    0.277 Billion USD
    World Rank (Jul-30-2023)
    18,598
    Market Cap (Jul-30-2023)
    0.180 Billion USD
    World Rank (Dec-25-2022)
    16,897
    Market Cap (Dec-25-2022)
    0.247 Billion USD
    World Rank (Jan-07-2022)
    16,291
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -12 Million USD
    Annual Results for Period Ending
    Jun-2020 ending year
    Headquarters Country
    Australia
    Yahoo @ ASX
    Company Profile

    Opthea is Biotechnology company with headquarters is in Australia.

    Opthea is committed to improving vision in patients suffering from retinal eye diseases.

    They are developing a novel therapeutic called OPT-302, a VEGF-C/D ‘trap’, to be used in conjunction with existing standard of care anti-VEGF-A therapies.

    Company Website
    OPTHEA

  2. Inozyme Pharma Inc.

    World Rank (Jan-05-2024)
    16,447
    Market Cap (Jan-05-2024)
    0.265 Billion USD
    World Rank (Jul-30-2023)
    17,663
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    25,394
    Market Cap (Dec-25-2022)
    0.048 Billion USD
    World Rank (Jan-07-2022)
    20,454
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Headquarters Country
    USA
    Company Profile
    Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.
    Company Website
    INOZYME PHARMA, INC.

  3. Atea Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    16,476
    Market Cap (Jan-05-2024)
    0.264 Billion USD
    World Rank (Jul-30-2023)
    16,155
    Market Cap (Jul-30-2023)
    0.284 Billion USD
    World Rank (Dec-25-2022)
    14,183
    Market Cap (Dec-25-2022)
    0.382 Billion USD
    World Rank (Jan-07-2022)
    11,890
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Revenue in USD
    351 Million USD
    Annual Net Income in USD
    121 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Atea is a Clinical Stage Biopharmaceutical company. It is focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life threatening viral diseases. The company annual revenue is 13.6 million USD and 6,904 employees as on 2019. The headquarters is in USA.
    Company Website
    ATEA PHARMACEUTICALS, INC.

  4. Allakos

    World Rank (Jan-05-2024)
    16,990
    Market Cap (Jan-05-2024)
    0.239 Billion USD
    World Rank (Jul-30-2023)
    13,456
    Market Cap (Jul-30-2023)
    0.447 Billion USD
    World Rank (Dec-25-2022)
    10,705
    Market Cap (Dec-25-2022)
    0.659 Billion USD
    World Rank (Jan-07-2022)
    13,924
    Market Cap (Jan-07-2022)
    0.46 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -153 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    ALLAKOS is Biotechnology sector company with headquarters is in USA.They are developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases
    Company Website
    ALLAKOS

  5. Concert Pharmaceuticals

    World Rank (Jan-05-2024)
    17,221
    World Rank (Jul-30-2023)
    17,221
    Market Cap (Jul-30-2023)
    0.520 Billion USD
    World Rank (Dec-25-2022)
    17,221
    Market Cap (Dec-25-2022)
    0.233 Billion USD
    World Rank (Jan-07-2022)
    22,351
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Net Income in USD
    -75 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Company Profile

    Concert Pharmaceuticals is a Clinical Stage Biopharmaceutical company platform drives product innovation and enabling to design drug candidates to create differentiated properties and address patient needs. The company annual revenue is 7.9 million USD and 70 employees as on 2020. The headquarters is in USA.

    Company Website
    CONCERT PHARMACEUTICALS

  6. Gossamer Bio

    World Rank (Jan-05-2024)
    17,483
    Market Cap (Jan-05-2024)
    0.217 Billion USD
    World Rank (Jul-30-2023)
    20,610
    Market Cap (Jul-30-2023)
    0.122 Billion USD
    World Rank (Dec-25-2022)
    18,593
    Market Cap (Dec-25-2022)
    0.180 Billion USD
    World Rank (Jan-07-2022)
    9,969
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -234 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Gossamer Bio is a Clinical Stage Biopharmaceutical company. It is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The company estimated annual revenue is currently 6 million USD per year and 118 employees as on 2020 . The headquarters is in USA.
    Company Website
    GOSSAMER BIO

  7. Prelude Therapeutics Inc

    World Rank (Jan-05-2024)
    17,714
    Market Cap (Jan-05-2024)
    0.207 Billion USD
    World Rank (Jul-30-2023)
    17,807
    Market Cap (Jul-30-2023)
    0.209 Billion USD
    World Rank (Dec-25-2022)
    16,968
    Market Cap (Dec-25-2022)
    0.244 Billion USD
    World Rank (Jan-07-2022)
    13,662
    Market Cap (Jan-07-2022)
    0.48 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -111 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Prelude Therapeutics is a Clinical Stage Biopharmaceutical company. The company estimated annual revenue is currently 8.5 million USD per year and 55 employees as on 2019. The headquarters is in USA.
    Company Website
    PRELUDE THERAPEUTICS INC

  8. Berkeley Lights Inc.

    World Rank (Jan-05-2024)
    17,881
    World Rank (Jul-30-2023)
    17,881
    World Rank (Dec-25-2022)
    17,881
    Market Cap (Dec-25-2022)
    0.205 Billion USD
    World Rank (Jan-07-2022)
    11,810
    Market Cap (Jan-07-2022)
    0.65 Billion USD
    Annual Revenue in USD
    85 Million USD
    Annual Net Income in USD
    -71 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile
    Berkeley Lights is a Cellular Therapies, Biopharmaceuticals and Other Cell Based Products company. The company annual revenue is 59.2 million USD and 210 employees as on 2020. The headquarters is in USA.
    Company Website
    BERKELEY LIGHTS, INC.

  9. Immuneering Corp

    World Rank (Jan-05-2024)
    17,967
    Market Cap (Jan-05-2024)
    0.198 Billion USD
    World Rank (Jul-30-2023)
    15,921
    Market Cap (Jul-30-2023)
    0.296 Billion USD
    World Rank (Dec-25-2022)
    20,921
    Market Cap (Dec-25-2022)
    0.115 Billion USD
    World Rank (Jan-07-2022)
    14,690
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Headquarters Country
    USA
    Company Profile
    Biopharmaceutical company with headquarters is in USA.
    Company Website
    IMMUNEERING CORP

  10. Golden Biotechnology Corporation

    World Rank (Jan-05-2024)
    18,273
    Market Cap (Jan-05-2024)
    0.186 Billion USD
    World Rank (Jul-30-2023)
    17,639
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    15,859
    Market Cap (Dec-25-2022)
    0.294 Billion USD
    World Rank (Jan-07-2022)
    7,790
    Market Cap (Jan-07-2022)
    1.39 Billion USD
    Headquarters Country
    Taiwan
    Company Profile
    Golden Biotechnology Corporation is a biopharmaceutical company focuses on discovery and clinical development of innovative therapeutic new drugs (NCE) and dedicated to improving quality of life by developing products that prevent and treat diseases. The headquarters is in Taiwan.
    Facts About Company
    Golden Biotechnology Corporation annual revenue for year ending Dec-2022 was 217 million TWD.
    Company Website
    GOLDEN BIOTECHNOLOGY CORPORATION

Share